September 12, 2022
Endo Pharmaceuticals is asking a New York bankruptcy judge to pause thousands of state and local government suits against the company over its opioid sales, saying it needs breathing room to finish its Chapter 11 reorganization.
August 22, 2022
An Endo International affiliate Monday asked a New York bankruptcy judge to prevent another pharmaceutical company from canceling pre-Chapter 11 asset purchase and drug licensing deals, denying that it breached the contracts.
August 18, 2022
Creditors of Endo International told a New York bankruptcy judge Thursday that they will seek to file an alternative to Endo's proposed Chapter 11 sale, as the drugmaker made its first court appearance in its bankruptcy case.
August 17, 2022
Besieged by opioid crisis lawsuits, drugmaker Endo International has filed for Chapter 11 protection in a New York bankruptcy court, saying a deal will cut $6 billion in debt and earmark $550 million for claims it contributed to an epidemic of narcotic abuse.
August 17, 2022
Besieged by opioid crisis lawsuits, drugmaker Endo International has filed for Chapter 11 protection in a New York bankruptcy court, saying a deal will cut $6 billion in debt and earmark $550 million for claims it contributed to an epidemic of narcotic abuse.